1.The correlation of advanced gastric carcinoma′s tri-phases enhancement characteristics with 64-slice spiral computed tomography and its histological types
Ruxin ZOU ; Yang ZHOU ; Zhichang BA ; Lin SUI ; Yingqiao ZHANG ; Naijian SHANG
Practical Oncology Journal 2013;(6):549-553
Objective To investigate the correlation of extent and pattern of computed tomography ( CT) enhancement of tumor lesions and histological types in advanced gastric carcinoma .Methods A total of 121 ca-ses of advanced gastric carcinoma were included in this study .Tri-phase enchanced 64-slice spiral CT scan-ning was performed before operation for every patient .We judged the extent lesions′of and pattern of enhance-ment using axial images combined with reconstruction of VR ,MPR and MIP.Then the radiographic result of every subject was compared with its corresponding postoperative histological type after operation .Results In the pres-ent study,the correlation of extent of CT enhancement of tumor lesions and histological types were as follows :ade-nocarcinoma patients were mostly with moderate enhancement ( n=57,61.3%),mucinous adenocarcinoma pa-tients were mostly with mild enhancement (n=7,46.7%).While obvious enhancement were mostly observed in patients with signet ring cell carcinoma(n=8,61.5%).The correlation of pattern of CT enhancement of tumor lesions and histological types were as follows:adenocarcinoma patients were mostly with well -distributed en-hancement(n=58,62.4%),while endothecium obvious enhancement were mostly seen in patients with mucinous adenocarcinoma(n=13,86.7%)and signet ring cell carcinoma (n=7,58.3%).Conclusions There are signif-icant correlation between advanced gastric carcinoma′s tri-phases enhancement characteristics with 64-slice spiral CT and its histological types .Judging histological type using 64-slice spiral CT before operation is useful for formulating and optimizing the therapeutic regimen for gastric cancer patients ,and it is significant for observing the tumors′biological behavior and judging the curative effect .
2.Technology optimization and in vitro anti-tumor effect evaluation of reactive oxygen species-responsive metho-trexate-modified paclitaxel/icariin micelles
Naijian ZOU ; Liang KONG ; Lei CHANG ; Pengbo WAN ; Xiaolin JIANG ; Mingdian YUAN ; Yingqiang LU
China Pharmacy 2025;36(3):285-292
OBJECTIVE To prepare reactive oxygen species (ROS)-responsive methotrexate (MTX)-modified paclitaxel (PTX)/icariin (ICA) micelles (MTX-oxi-Ms@PTX/ICA), and perform technology optimization and in vitro anti-tumor effect evaluation. METHODS Synergistic toxicity concentration range of PTX and ICA was screened by synergistic toxicity test. The micelles were prepared by thin film hydration method, and their technology was optimized by response surface methodology. The fundamental characteristics of the micelles prepared by the optimal technology were evaluated. The micelles’ cytotoxicity, targeting ability to renal carcinoma RENCA cells of mice, and their inhibitory effects on invasion and migration were assessed. RESULTS Results of synergistic toxicity experiments demonstrated that the strongest synergistic effect occurred when PTX concentrations ranged from 2.5 to 10 μmol/L and ICA concentrations ranged from 5 to 15 μmol/L. The optimal technology of MTX-oxi-Ms@PTX/ ICA was determined to include 80 mg Soluplus®, Soluplus® and TPGS1000 mass ratio of 4∶1 (mg/mg), 2 mg DSPE-PEG2000-TK- PEG5000, 2 mg DSPE-PEG2000-MTX, 1 mg PTX, and 1.5 mg ICA, with a hydration temperature of 35 ℃ and a formulation volume of 5 mL. Under the optimal conditions, average encapsulation efficiency of PTX and ICA in 3 batches of MTX-oxi- Ms@PTX/ICA reached 92.75%, the critical micelle concentration (CMC) was 0.007 9 mg/mL, the particle size was (62.09±1.68) nm, the polydispersity index (PDI) was 0.046±0.032, and the Zeta potential was (-2.47±0.15) mV. Within 30 days of placement, there was no significant change E-mail:yingqiang_1126@163.com in particle size and polydispersity index of micelle. In vitro release experiments showed that MTX-oxi-Ms@PTX/ICA released drugs more rapidly in oxidative environments. The half maximal inhibitory concentration of MTX-oxi-Ms@PTX/ICA against RENCA cells was (5.170±0.036) μmol/L. In vitro cellular uptake experiments indicated that compared with unmodified micelles, MTX modified micelles had stronger targeting effects on cancer cells, and also significantly enhanced the inhibitory ability of invasion and migration of RENCA cells (P<0.05). CONCLUSIONS MTX-oxi-Ms@PTX/ICA micelles are successfully prepared, which exhibit high encapsulation efficiency, low critical micelle concentration, and good stability. These micelles demonstrate significant cytotoxicity against RENCA cells and effectively inhibit cancer cell invasion and migration.